Bausch Health Cos Total Assets 2010-2024 | BHC

Bausch Health Cos total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Bausch Health Cos Annual Total Assets
(Millions of US $)
2023 $27,350
2022 $25,686
2021 $29,202
2020 $31,199
2019 $33,863
2018 $32,492
2017 $37,497
2016 $43,529
2015 $48,965
2014 $26,305
2013 $27,971
2012 $17,950
2011 $13,108
2010 $10,795
2009 $2,059
Bausch Health Cos Quarterly Total Assets
(Millions of US $)
2024-09-30 $26,540
2024-06-30 $26,495
2024-03-31 $26,913
2023-12-31 $27,350
2023-09-30 $27,064
2023-06-30 $25,503
2023-03-31 $25,445
2022-12-31 $25,686
2022-09-30 $26,298
2022-06-30 $28,171
2022-03-31 $29,090
2021-12-31 $29,202
2021-09-30 $29,252
2021-06-30 $30,042
2021-03-31 $30,197
2020-12-31 $31,199
2020-09-30 $31,562
2020-06-30 $31,396
2020-03-31 $31,865
2019-12-31 $33,863
2019-09-30 $31,667
2019-06-30 $32,354
2019-03-31 $32,551
2018-12-31 $32,492
2018-09-30 $33,777
2018-06-30 $34,448
2018-03-31 $35,798
2017-12-31 $37,497
2017-09-30 $39,974
2017-06-30 $41,733
2017-03-31 $42,333
2016-12-31 $43,529
2016-09-30 $45,761
2016-06-30 $47,662
2016-03-31 $49,020
2015-12-31 $48,965
2015-09-30 $48,455
2015-06-30 $48,343
2015-03-31 $38,566
2014-12-31 $26,305
2014-09-30 $27,060
2014-06-30 $27,896
2014-03-31 $27,989
2013-12-31 $27,971
2013-09-30 $28,204
2013-06-30 $19,782
2013-03-31 $17,486
2012-12-31 $17,950
2012-09-30 $14,146
2012-06-30 $14,020
2012-03-31 $13,620
2011-12-31 $13,108
2011-09-30 $11,818
2011-06-30 $11,828
2011-03-31 $11,688
2010-12-31 $10,795
2010-09-30 $11,136
2010-06-30 $2,030
2010-03-31 $2,005
2009-12-31 $2,059
2009-09-30 $2,022
2009-06-30 $2,058
2009-03-31 $1,557
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00